MDxHealth SA
MDXH3.400USD
+0.250+7.94%
交易中 （美東）報價延遲15分鐘
168.29M總市值
虧損本益比TTM
關於 MDxHealth SA 公司
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
MDxHealth SA簡介
公司代碼MDXH
公司名稱MDxHealth SA
上市日期Jun 26, 2006
CEOMr. Michael K. McGarrity
員工數量312
證券類型Ordinary Share
年結日Jun 26
公司地址CAP Business Center
城市HERSTAL
上市交易所NASDAQ Capital Market Consolidated
國家Belgium
郵編4040
電話3243642070
網址https://mdxhealth.com/
公司代碼MDXH
上市日期Jun 26, 2006
CEOMr. Michael K. McGarrity
MDxHealth SA公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. John Bellano
Mr. John Bellano
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Rudi Marien
Mr. Rudi Marien
Non-Executive Director
Non-Executive Director
--
--
Mme. Ruth Devenyns
Mme. Ruth Devenyns
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Walter M. (Wally) Narajowski
Mr. Walter M. (Wally) Narajowski
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2023
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
United States of America
69.71M
99.31%
Europe
476.00K
0.68%
Rest of the world
9.00K
0.01%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 12月12日 週五
更新時間: 12月12日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
其他
53.75%
持股股東
持股股東
佔比
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
其他
53.75%
股東類型
持股股東
佔比
Investment Advisor
20.86%
Investment Advisor/Hedge Fund
14.93%
Venture Capital
9.52%
Individual Investor
6.67%
Corporation
4.93%
Hedge Fund
1.09%
Research Firm
0.12%
其他
41.87%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
49
21.80M
44.04%
-2.18M
2025Q2
45
28.07M
56.71%
+2.44K
2025Q1
47
29.82M
60.25%
-710.83K
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Bleichroeder LP
7.38M
14.91%
--
--
Jun 30, 2025
AWM Investment Company, Inc.
5.22M
10.55%
--
--
Jun 30, 2025
MVM Partners LLP
4.70M
9.5%
--
--
Jun 30, 2025
Lytton (Laurence W)
3.95M
7.98%
+1.06M
+36.63%
Dec 31, 2024
Genomic Health, Inc.
2.44M
4.93%
+1.50M
+159.38%
Sep 27, 2024
Samjo Capital, LLC
1.54M
3.1%
-96.72K
-5.93%
Jun 30, 2025
Perkins Capital Management, Inc.
1.42M
2.87%
+238.55K
+20.19%
Jun 30, 2025
Kennedy Capital Management LLC
47.80K
0.1%
+47.80K
--
Aug 31, 2025
Northern Trust Global Investments Limited
411.94K
0.83%
+3.93K
+0.96%
Jun 30, 2025
FreeGulliver LLC
123.55K
0.25%
+123.55K
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.04%
iShares Micro-Cap ETF
佔比0.04%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
MDxHealth SA的前五大股東是誰？
MDxHealth SA的前五大股東如下：
Bleichroeder LP持有股份：7.38M佔總股份比例：14.91%。
AWM Investment Company, Inc.持有股份：5.22M佔總股份比例：10.55%。
MVM Partners LLP持有股份：4.70M佔總股份比例：9.50%。
Lytton (Laurence W)持有股份：3.95M佔總股份比例：7.98%。
Genomic Health, Inc.持有股份：2.44M佔總股份比例：4.93%。
Bleichroeder LP持有股份：7.38M佔總股份比例：14.91%。
AWM Investment Company, Inc.持有股份：5.22M佔總股份比例：10.55%。
MVM Partners LLP持有股份：4.70M佔總股份比例：9.50%。
Lytton (Laurence W)持有股份：3.95M佔總股份比例：7.98%。
Genomic Health, Inc.持有股份：2.44M佔總股份比例：4.93%。
MDxHealth SA的前三大股東類型是什麼？
MDxHealth SA 的前三大股東類型分別是：
Bleichroeder LP
AWM Investment Company, Inc.
MVM Partners LLP
Bleichroeder LP
AWM Investment Company, Inc.
MVM Partners LLP
有多少機構持有MDxHealth SA(MDXH)的股份？
截至2025Q3，共有49家機構持有MDxHealth SA的股份，合計持有的股份價值約為21.80M，占公司總股份的44.04% 。與2025Q2相比，機構持股有所增加，增幅為-12.67%。
哪個業務部門對MDxHealth SA的收入貢獻最大？
在FY2023，--業務部門對MDxHealth SA的收入貢獻最大，創收--，占總收入的--% 。
